Nxera Pharma Co (TSE:4565) Other Long-Term Liabilities : 円4,740 Mil (As of Mar. 2025)

View and export this data going back to 2004. Start your Free Trial

What is Nxera Pharma Co Other Long-Term Liabilities?

Nxera Pharma Co's other long-term liabilities for the quarter that ended in Mar. 2025 was 円4,740 Mil.

Nxera Pharma Co's quarterly other long-term liabilities declined from Sep. 2024 (円6,879 Mil) to Dec. 2024 (円6,138 Mil) and declined from Dec. 2024 (円6,138 Mil) to Mar. 2025 (円4,740 Mil).

Nxera Pharma Co's annual other long-term liabilities declined from Dec. 2022 (円7,831 Mil) to Dec. 2023 (円6,003 Mil) but then increased from Dec. 2023 (円6,003 Mil) to Dec. 2024 (円6,138 Mil).

Nxera Pharma Co Other Long-Term Liabilities Historical Data

The historical data trend for Nxera Pharma Co's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nxera Pharma Co Other Long-Term Liabilities Chart

Nxera Pharma Co Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Long-Term Liabilities

Get a 7-Day Free Trial

4,646.00

3,248.00

7,831.00

6,003.00

6,138.00

Nxera Pharma Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Long-Term Liabilities	Get a 7-Day Free Trial															6,064.00	7,586.00	6,879.00	6,138.00	4,740.00

Nxera Pharma Co Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Nxera Pharma Co Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Nxera Pharma Co's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Nxera Pharma Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nxera Pharma Co Ltd (TSE:4565) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

SOLTF:USA

Address

Midtown East, 9-7-2 Akasaka Minato-ku, Tokyo, JPN, 107-0052

Website

https://www.nxera.life

Nxera Pharma Co Ltd is a science and technology-led biopharmaceutical company. Its activities are drug discovery, drug development and the commercialization of pharmaceutical products. The focus is to discover new medicines for unmet medical needs, including novel small molecules, peptides and therapeutic antibodies targeting G Protein Coupled Receptors (GPCRs).

Nxera Pharma Co Headlines

No Headlines